Published in Vaccine Weekly, January 20th, 2010
The discovery stems from the team's effort to carry out a genetic analysis of tumor cells. Based on these data, the scientists have identified a genetic marker to accurately diagnose the facial cancers, called devil facial tumor disease (DFTD).
The findings, which open new avenues for research into treatments and vaccines, will appear in the journal Science on January...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly